Feature|Articles|December 10, 2023
- Pharmaceutical Executive: December 2023
- Volume 43
- Issue 12
Pharmaceutical Executive: December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Finding that Sparkover 2 years ago
Remote Reliance: The Rise of Oncology Home Careover 2 years ago
It’s Always Important to Remember: Leaders Make Mistakesover 2 years ago
FDA, Industry Face Challenges in the Year Aheadover 2 years ago
Navigating the Future: Key Market Access Trends to Watch in ’24over 2 years ago
Reflecting on 2023Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5